Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (181)
  2. Journal Article (123)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (3)
  7. Book Section (1)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (339)
  2. Department of Medicine (339)
  3. Hematologic Malignancies, Division of (339)
  4. Lymphoma (339)
  5. Population Sciences Research Program (220)
  6. Survivorship Research (141)

More Groups

People
  1. Steven Horwitz (220)
  2. Andrew Zelenetz (119)
  3. Paul Hamlin (107)
  4. Ariela Noy (106)
  5. David Straus (96)
  6. Matthew Matasar (95)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (136)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (21)
  4. Blood Advances (15)
  5. Journal of the American Academy of Dermatology (13)
  6. Leukemia and Lymphoma (13)

More Publications

Publishers
  1. American Society of Hematology (154)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (24)
  4. Elsevier Inc. (21)
  5. Taylor & Francis Group (14)
  6. Mosby Elsevier (13)

More Publishers

Results (339)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Venetoclax re-treatment of chronic lymphocytic leukemia (CLL) patients after a previous venetoclax-based regimen
    Meeting Abstract

    Thompson, M. C.; Allan, J. N.; Sail, K.; Manzoor, B. S.; Pu, J. J.; Barr, P. M.; Coombs, C. C.; Schuster, S. J.; Skarbnik, A.; Rhodes, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma: Primary efficacy and safety analysis of the phase 2 CheckMate 436 study
    Meeting Abstract

    Santoro, A.; Moskowitz, A. J.; Ferrari, S.; Carlo-Stella, C.; Fanale, M. A.; Francis, S.; Sacchi, M.; Savage, K. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Multi-center phase II study of oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Ruan, J.; Moskowitz, A. J.; Mehta-Shah, N.; Sokol, L.; Chen, Z.; Rahim, R.; Song, W.; Van Besien, K.; Horwitz, S. M.; Rutherford, S. C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • End of treatment peripheral blood T-cell receptor gene rearrangement evaluation for minimal residual disease evaluation in peripheral T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Fehniger, T. A.; Jacobsen, E. D.; Peterson, K.; Kahl, B. S.; Bartlett, N. L.; Cashen, A. F.; Ghobadi, A.; Fischer, A.; Reagan, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: The largest multicenter retrospective analysis
    Meeting Abstract

    Mehta-Shah, N.; Kommalapati, A.; Teja, S.; Cashen, A. F.; Dahi, P. B.; Sauter, C. S.; Moskowitz, A. J.; Jacobsen, E. D.; William, B. M.; Ozga, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CD5-positive marginal zone lymphoma: Clinical characteristics of the MSKCC Cohort, and comparison with the CD5-negative population
    Meeting Abstract

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Lia Palomba, M.; Noy, A.; Matasar, M. J.; Caron, P.; Hamilton, A.; Hamlin, P. A.; Kumar, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and follow-up post-surgery of women with BIA-ALCL operated at a single institution
    Meeting Abstract

    Ghione, P.; Vorstenbosch, J.; Cordeiro, P. G.; Arcila, M. E.; Moskowitz, A. J.; Owens, C.; Galasso, N.; Nelson, J. A.; Dogan, A.; McCarthy, C. M.; more...
    Blood (2020)

    Fulltext@MSK | Save